Soderquist Ola 4
4 · BIOXYTRAN, INC · Filed Oct 28, 2024
Insider Transaction Report
Form 4
BIOXYTRAN, INCBIXT
Soderquist Ola
CFO10% Owner
Transactions
- Other
preferred
2024-10-25$0.55/sh+10,197,611$5,557,698→ 14,104,671 total - Other
preferred
2024-10-25$0.01/sh−100,000$500→ 14,004,671 total - Other
common
2024-10-25$0.00/sh+500,000$500→ 500,000 total
Footnotes (2)
- [F1]The shares were issued as payment for the sale of NDPD Pharma to Bioxytran
- [F2]A 1:5 exchange Preferred Stock (earlier issued under Section 16b-3) into shares of Common Stock.